Stock Events

Stock Events

UroGen Pharma (URGN) Q1 2023 Earnings

11MayConfirmed

Aug 22

Nov 22

Q4 2022

Q1 2023

-1.33

-1.24

-1.16

-1.07

Details

Expected EPS

-1.33

Actual EPS

-1.3

Surprise EPS

0.03

Surprise Percent

+2.26%

Description

UroGen Pharma (URGN) has reported earnings of -1.3 per share for Q1 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.